Artesunate may inhibit liver fibrosis via the FAK/Akt/-catenin pathway in LX-2 cells | |
Lv, Jian; Bai, Ruidan; Wang, Li; Gao, Jiefang; Zhang, Hong | |
刊名 | BMC PHARMACOLOGY & TOXICOLOGY |
2018 | |
卷号 | 19 |
关键词 | Artesunate Liver fibrosis Hepatic stellate cells Activation FAK/Akt/beta-catenin |
ISSN号 | 2050-6511 |
DOI | 10.1186/s40360-018-0255-9 |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4225542 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Lv, Jian,Bai, Ruidan,Wang, Li,et al. Artesunate may inhibit liver fibrosis via the FAK/Akt/-catenin pathway in LX-2 cells[J]. BMC PHARMACOLOGY & TOXICOLOGY,2018,19. |
APA | Lv, Jian,Bai, Ruidan,Wang, Li,Gao, Jiefang,&Zhang, Hong.(2018).Artesunate may inhibit liver fibrosis via the FAK/Akt/-catenin pathway in LX-2 cells.BMC PHARMACOLOGY & TOXICOLOGY,19. |
MLA | Lv, Jian,et al."Artesunate may inhibit liver fibrosis via the FAK/Akt/-catenin pathway in LX-2 cells".BMC PHARMACOLOGY & TOXICOLOGY 19(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论